Can Generative-Model-Based Drug Design Become a New Normal in Drug Discovery?
Author:
Affiliation:
1. Bioland Laboratory (Guangzhou Regenerative Medicine and Health - Guangdong Laboratory), Guangzhou 510530, China
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c02042
Reference8 articles.
1. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors
2. Automated design of ligands to polypharmacological profiles
3. Discovery of Pyrazolo[3,4-d]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation
4. Molecular de-novo design through deep reinforcement learning
5. Structure-based de novo drug design using 3D deep generative models
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Application scenario-oriented molecule generation platform developed for drug discovery;Methods;2024-02
2. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR;Nature Reviews Drug Discovery;2023-12-08
3. The GenAI is out of the bottle: generative artificial intelligence from a business model innovation perspective;Review of Managerial Science;2023-09-13
4. The GenAI is out of the bottle: generative artificial intelligence from a business model innovation perspective;REV MANAG SCI;2023
5. Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design;ACS MED CHEM LETT;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3